chr22-17105867-T-C
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_014339.7(IL17RA):c.958T>C(p.Trp320Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00389 in 1,613,944 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W320C) has been classified as Uncertain significance.
Frequency
Consequence
NM_014339.7 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 51Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- chronic mucocutaneous candidiasisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00233 AC: 355AN: 152200Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00173 AC: 435AN: 251206 AF XY: 0.00170 show subpopulations
GnomAD4 exome AF: 0.00405 AC: 5917AN: 1461626Hom.: 19 Cov.: 33 AF XY: 0.00386 AC XY: 2806AN XY: 727132 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00233 AC: 355AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.00223 AC XY: 166AN XY: 74480 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Immunodeficiency 51 Uncertain:1Benign:1
IL17RA NM_014339.6 exon 11 p.Trp320Arg (c.958T>C): This variant has been reported in the literature in 1 individual with sarcoidosis, segregating with disease in 2 affected family members; of note, additional variants were identified in this family that the authors believed were suggestive of disease (Besnard 2018 PMID:29554915). This variant is present in 0.3% (443/129026) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-17586757-T-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:340587). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
- -
Familial Candidiasis, Recessive Uncertain:1
- -
not provided Uncertain:1
Observed with additional variants in IL17RA in a patient with unclassified antibody deficiency in published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (PMID: 35874679); Identified with a second IL17RA variant in a patient with chronic mucocutaneous candidiasis in published literature, however this patient had a variant in STAT1 that may have also contributed to the phenotype (PMID: 34390440); Reported in homozygous state in a patient with juvenile paracoccidioidomycosis in a thesis (Franco CAA. (2017) https://bibliotecadigital.udea.edu.co/dspace/handle/10495/39993); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29554915, O'Leary[abstract]2022, 34662886, 34390440, Franco[thesis]2017, 35874679) -
IL17RA-related disorder Uncertain:1
The IL17RA c.958T>C variant is predicted to result in the amino acid substitution p.Trp320Arg. This variant has been reported in the heterozygous state in individuals with sarcoidosis (Besnard et al. 2018. PubMed ID: 29554915). Of note, all of those individuals also had variants in other genes in additional to the IL17RA c.958T>C variant. This variant is reported in 0.34% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at